These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3122257)

  • 1. Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position task in rats.
    Sahgal A
    Psychopharmacology (Berl); 1987; 93(2):243-9. PubMed ID: 3122257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin and amphetamine, but not desglycinamide vasopressin, impair positively reinforced visual attention performance in rats.
    Sahgal A
    Behav Brain Res; 1988 Jul; 29(1-2):35-42. PubMed ID: 3401320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vasopressin, des-glycinamide vasopressin and amphetamine on a combined passive and active avoidance task.
    Sahgal A
    Psychopharmacology (Berl); 1986; 90(4):494-8. PubMed ID: 3101105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task.
    Vawter MP; De Wied D; Van Ree JM
    Neuropeptides; 1997 Oct; 31(5):489-94. PubMed ID: 9413027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?
    Ettenberg A; van der Kooy D; Le Moal M; Koob GF; Bloom FE
    Behav Brain Res; 1983 Mar; 7(3):331-50. PubMed ID: 6838716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats.
    Packard MG; Ettenberg A
    Regul Pept; 1985 May; 11(1):51-63. PubMed ID: 4011956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of AVP and DGAVP on the exploratory activity of rats.
    Skopková J; Lát J; Dvorská I; Hrbas P; Radil T
    Peptides; 1987; 8(5):785-90. PubMed ID: 3432126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposing effects of vasopressin on matching versus non-matching to position: further evidence for response, not memory, modulation.
    Sahgal A; Keith AB; Lloyd S
    Psychopharmacology (Berl); 1990; 102(1):130-5. PubMed ID: 2392501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on desglycinamide arginine vasopressin and scopolamine in a modified/lever-touch autoshaping model of learning/memory in rats.
    Mundy WR; Iwamoto ET
    Pharmacol Biochem Behav; 1987 Jun; 27(2):307-15. PubMed ID: 3628445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasopressin and analogue [d(CH2)1(5), Tyr (Me)2, Val4, delta 3Pro7)] AVP on learning and memory in rats chronically treated with ethanol.
    Car H; Borawska MH; Wiśniewski K
    J Physiol Pharmacol; 1994 Mar; 45(1):163-71. PubMed ID: 8043905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of subcutaneous administration of arginine-8-vasopressin on the electroencephalogram of conscious rats are mediated by peripheral vasopressin V1 receptors.
    Ebenezer IS
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):315-21. PubMed ID: 7934310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of a trimethyltin-induced learning deficit by desglycinamide-8-arginine vasopressin.
    Sparber SB; Cohen CA; Messing RB
    Life Sci; 1988; 42(2):171-7. PubMed ID: 3336276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of DGAVP on verbal memory.
    Pietrowsky R; Fehm-Wolfsdorf G; Born J; Fehm HL
    Peptides; 1988; 9(6):1361-6. PubMed ID: 3247253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of desglycinamide-(Arg8)-vasopressin (DGAVP) on the acquisition of free-choice alcohol drinking in rhesus monkeys.
    Kornet M; Goosen C; Ribbens LG; Van Ree JM
    Alcohol Clin Exp Res; 1991 Feb; 15(1):72-9. PubMed ID: 2024735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebroventricular application of a vasopressin antagonist peptide prevents the behavioral actions of vasopressin.
    Ettenberg A
    Behav Brain Res; 1984 Dec; 14(3):201-11. PubMed ID: 6549259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin.
    Ettenberg A; Le Moal M; Koob GF; Bloom FE
    Pharmacol Biochem Behav; 1983 Apr; 18(4):645-7. PubMed ID: 6867069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Greater task difficulty amplifies the facilitatory effect of des-glycinamide arginine vasopressin on appetitively motivated learning.
    Messing RB; Sparber SB
    Behav Neurosci; 1985 Dec; 99(6):1114-9. PubMed ID: 3843542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-related influence of arginine-vasopressin on a passive avoidance behavior: effect of rearing conditions.
    Crine AF
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):379-84. PubMed ID: 6541358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of DDAVP, a vasopressin analog, on delayed matching behavior in the pigeon.
    Teal JJ; Evans HL
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1123-7. PubMed ID: 7163345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.